دورية أكاديمية

Title evaluation of FluSight influenza forecasting in the 2021–22 and 2022–23 seasons with a new target laboratory-confirmed influenza hospitalizations.

التفاصيل البيبلوغرافية
العنوان: Title evaluation of FluSight influenza forecasting in the 2021–22 and 2022–23 seasons with a new target laboratory-confirmed influenza hospitalizations.
المؤلفون: Mathis, Sarabeth M., Webber, Alexander E., León, Tomás M., Murray, Erin L., Sun, Monica, White, Lauren A., Brooks, Logan C., Green, Alden, Hu, Addison J., Rosenfeld, Roni, Shemetov, Dmitry, Tibshirani, Ryan J., McDonald, Daniel J., Kandula, Sasikiran, Pei, Sen, Yaari, Rami, Yamana, Teresa K., Shaman, Jeffrey, Agarwal, Pulak, Balusu, Srikar
المصدر: Nature Communications; 7/26/2024, Vol. 15 Issue 1, p1-13, 13p
مصطلحات موضوعية: INFLUENZA, FORECASTING, HOSPITAL admission & discharge, SEASONS, HOSPITAL care, SEASONAL influenza
مصطلحات جغرافية: UNITED States
مستخلص: Accurate forecasts can enable more effective public health responses during seasonal influenza epidemics. For the 2021–22 and 2022–23 influenza seasons, 26 forecasting teams provided national and jurisdiction-specific probabilistic predictions of weekly confirmed influenza hospital admissions for one-to-four weeks ahead. Forecast skill is evaluated using the Weighted Interval Score (WIS), relative WIS, and coverage. Six out of 23 models outperform the baseline model across forecast weeks and locations in 2021–22 and 12 out of 18 models in 2022–23. Averaging across all forecast targets, the FluSight ensemble is the 2nd most accurate model measured by WIS in 2021–22 and the 5th most accurate in the 2022–23 season. Forecast skill and 95% coverage for the FluSight ensemble and most component models degrade over longer forecast horizons. In this work we demonstrate that while the FluSight ensemble was a robust predictor, even ensembles face challenges during periods of rapid change. This manuscript evaluates forecasts of laboratory-confirmed influenza hospital admissions, a new target for influenza forecasting in the United States. Across two influenza seasons, the FluSight ensemble is robust compared to submitted models. [ABSTRACT FROM AUTHOR]
Copyright of Nature Communications is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:20411723
DOI:10.1038/s41467-024-50601-9